Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 287-294

  Wu, Feng ^a   Feng, Jin Zhong ^a   Qiu, Yi Hua ^a   Yu, Feng Bin ^a   Zhang, Jian Zhong ^a   Zhou, Wei ^a   Yu, Feng ^a   Wang, Guo Kun ^b   An, Li Na ^b   Ni, Fei Hua ^b   Wu, Hong ^b   Zhao, Xian Xian ^b   Qin, Yong Wen ^b   Luo, He De ^a  

^a PLA 98th Hospital   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aortic remodeling; Endothelial dysfunction; Inflammation; Nitric oxide; Oxidative stress; Receptor for advanced glycation end products; Sinoaortic denervation

Indexed keywords

3 NITROTYROSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALDEHYDE REDUCTASE; COLLAGEN; MALONALDEHYDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA DISEASE; AORTA SINUS DENERVATION; ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODYNAMIC MONITORING; HEMODYNAMIC PARAMETERS; IMMUNOHISTOCHEMISTRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

AORTIC REMODELING; ENDOTHELIAL DYSFUNCTION; INFLAMMATION; NITRIC OXIDE; OXIDATIVE STRESS; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; SINOAORTIC DENERVATION;

ALDEHYDE REDUCTASE; ANIMALS; AORTA; AUTONOMIC DENERVATION; BAROREFLEX; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; LACTOYLGLUTATHIONE LYASE; MALE; MITOCHONDRIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; VASCULITIS;

EID: 84880397534     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.04.033     Document Type: Article

References (29)

1. Bernardi L. Clinical evaluation of arterial baroreflex activity in diabetes. Diabetes Nutr Metab 2000, 13:331-340.
2. Michas F., Manios E., Stamatelopoulos K., et al. Baroreceptor reflex sensitivity is associated with arterial stiffness in a population of normotensive and hypertensive patients. Blood Press Monit 2012, 17:155-159.
3. Cai G.J., Miao C.Y., Xie H.H., Lu L.H., Su D.F. Arterial baroreflex dysfunction promotes atherosclerosis in rats. Atherosclerosis 2005, 183:41-47.
4. Su D.F., Miao C.Y. Reduction of blood pressure variability: a new strategy for the treatment of hypertension. Trends Pharmacol Sci 2005, 26:388-390.
5. Lacolley P., Bezie Y., Girerd X., et al. Aortic distensibility and structural changes in sinoaortic-denervated rats. Hypertension 1995, 26:337-340.
6. Feng J., Luo H., Qiu Y., Zhou W., Yu F., Wu F. Down-regulation of DDAH2 and eNOS induces endothelial dysfunction in sinoaortic-denervated rats. Eur J Pharmacol 2011, 661:86-91.
7. Shen F.M., Zhang S.H., Xie H.H., Jing Q., Wang D.S., Su D.F. Early structure changes of aortic wall in sinoaortic denervated rats. Clin Exp Pharmacol Physiol 2006, 33:358-363.
8. Yu Y.S., Xie H.H., Li L., et al. Effects of low-dose ketanserin on atherosclerosis in rats and rabbits. Can J Physiol Pharmacol 2010, 88:1054-1060.
9. Li Y., Liu S., Zhang Z., et al. RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation. PLoS One 2012, 7:e35016.
10. Valencia J.V., Mone M., Zhang J., Weetall M., Buxton F.P., Hughes T.E. Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. Diabetes 2004, 53:743-751.
11. Hwang Y.C., Kaneko M., Bakr S., et al. Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J 2004, 18:1192-1199.
12. Hwang Y.C., Bakr S., Ellery C.A., Oates P.J., Ramasamy R. Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium. FASEB J 2003, 17:2331-2333.
13. Elks C.M., Mariappan N., Haque M., Guggilam A., Majid D.S., Francis J. Chronic NF-kB blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am J Physiol Ren Physiol 2009, 296:F298-F305.
14. Mariappan N., Soorappan R.N., Haque M., Sriramula S., Francis J. TNF-α-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol. Am J Physiol Heart Circ Physiol 2007, 293:H2726-H2737.
15. Norman R.G., Coleman T.G., Dent A.C. Continuous monitoring of arterial pressure indicates sinoaortic denervated rats are not hypertensive. Hypertension 1981, 3:119-125.
16. Meerwaldt R., Links T.P., Graaff R., et al. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 2005, 48:1637-1644.
17. Lal S., Szwergold B.S., Taylor A.H., et al. Metabolism of fructose-3-phosphate in the diabetic rat lens. Arch Biochem Biophys 1995, 318:191-199.
18. Thornalley P.J. Glyoxalase 1-structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 2003, 31:1343-1348.
19. Sarkar R., Meinberg E.G., Stanley J.C., Gordon D., Webb R.C. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 1996, 78:225-230.
20. Coughlan M.T., Thorburn D.R., Penfold S.A., et al. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. JAm Soc Nephrol 2009, 20:742-752.
21. Gao X., Zhang H., Schmidt A.M., Zhang C. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 2008, 295:H491-H498.
22. Guo C., Zeng X., Song J., et al. Asoluble receptor for advanced glycation end-products inhibits hypoxia/reoxygenation-induced apoptosis in rat cardiomyocytes via the mitochondrial pathway. Int J Mol Sci 2012, 13:11923-11940.
23. Knepler J.L., Taher L.N., Gupta M.P., et al. Peroxynitrite causes endothelial cell monolayer barrier dysfunction. Am J Physiol Cell Physiol 2001, 281:C1064-C1075.
24. Ishibashi Y., Matsui T., Takeuchi M., Yamagishi S. Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells. Horm Metab Res 2011, 43:731-734.
25. Ojima A., Ishibashi Y., Matsui T., et al. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression. Am J Pathol 2013, 182:132-141.
26. Ishibashi Y., Yamagishi S., Matsui T., et al. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level. Metabolism 2012, 61:1067-1072.
27. Zhang C., Chen H., Xie H.H., Shu H., Yuan W.J., Su D.F. Inflammation is involved in the organ damage induced by sinoaortic denervation in rats. JHypertens 2003, 21:2141-2148.
28. Wendt T., Harja E., Bucciarelli L., et al. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 2006, 185:70-77.
29. Kamide T., Kitao Y., Takeichi T., et al. RAGE mediates vascular injury and inflammation after global cerebral ischemia. Neurochem Int 2012, 60:220-228.